Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Eur J Clin Microbiol Infect Dis ; 31(7): 1435-42, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22048844

RESUMO

The purpose of this investigation was to describe the use of linezolid in pediatric inpatient facilities. A retrospective multicenter survey including data from nine participating tertiary care pediatric inpatient facilities in Germany and Austria was undertaken. Data on 126 off-label linezolid treatment courses administered to 108 patients were documented. The survey comprises linezolid treatment in a broad spectrum of clinical indications to children of all age groups; the median age was 6.8 years (interquartile range 0.6-15.5 years; range 0.1-21.2 years; ten patients were older than 18 years of age but were treated in pediatric inpatient units). Of the 126 treatment courses, 27 (21%) were administered to preterm infants, 64 (51%) to pediatric oncology patients, and 5% to patients soon after liver transplantation. In 25%, the infection was related to a medical device. Linezolid iv treatment was started after intensive pre-treatment (up to 11 other antibiotics for a median duration of 14 days) and changed to enteral administration in only 4% of all iv courses. In 39 (53%) of 74 courses administered to children older than 1 week and younger than 12 years of age, the dose was not adjusted to age-related pharmacokinetic parameters. In only 17 courses (13%) was a pediatric infectious disease consultant involved in the clinical decision algorithm. Linezolid seemed to have contributed to a favorable outcome in 70% of all treatment courses in this survey. Although retrospective, this survey generates interesting data on the off-label use of linezolid and highlights several important clinical aspects in which the use of this rescue antibiotic in children might be improved.


Assuntos
Acetamidas/uso terapêutico , Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Oxazolidinonas/uso terapêutico , Adolescente , Áustria , Criança , Pré-Escolar , Feminino , Alemanha , Hospitais Pediátricos , Humanos , Lactente , Recém-Nascido , Linezolida , Masculino , Uso Off-Label/estatística & dados numéricos , Estudos Retrospectivos , Resultado do Tratamento , Adulto Jovem
2.
Klin Padiatr ; 220(6): 348-52, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18949669

RESUMO

BACKGROUND: Recovery of cytomegalovirus (CMV)-specific T cell mediated immunity after allogeneic hematopoietic stem cell transplantation (SCT) is critical for protection against CMV disease. Tetramer-based technologies have been shown to be a sensitive tool in the enumeration of specific T cells, but have the disadvantage of HLA-restriction of the peptides. PATIENTS AND METHODS: In this pilot study, we tested the feasibility of a panel of 6 CMV-specific tetrameric HLA/CMV-peptide complexes to enumerate CMV-specific CD8 +T cells (CTLs). The reconstitution of CMV-specific CTLs was assessed in 16 children in the first year after allogeneic SCT (median age, 8 years). RESULTS: The presented assay covered more than 85% of our patients transplanted in the last 3 years. During CMV-reactivation, all 4 of the 16 analyzed patients with a high virus-load showed less than 10 CMV-specific CTLs/microl; out of these, three had not any detectable CMV-CTLs. On the other hand, five of the children with less than 10 CMV-specific CTLs/microl did not develop CMV reactivation. When enumeration of T cells was performed by means of different tetrameric HLA/CMV-peptide complexes simultaneously, the numbers of CMV-specific CTLs cells widely differed according to the HLA-type. CONCLUSIONS: Our pilot study suggests that enumeration of CMV-specific T cells by means of a panel of 6 tetramers might be a useful tool in the risk assessment for CMV reactivation in the majority of patients undergoing allogeneic SCT, but future trials have to evaluate whether this method is appropriate in tailoring antiviral therapy in the individual patient.


Assuntos
Alelos , Especificidade de Anticorpos/imunologia , Antígenos Virais/imunologia , Linfócitos T CD8-Positivos/imunologia , Infecções por Citomegalovirus/imunologia , Citomegalovirus/imunologia , Transplante de Células-Tronco Hematopoéticas/métodos , Neoplasias/terapia , Infecções Oportunistas/imunologia , Adolescente , Criança , Citomegalovirus/genética , Infecções por Citomegalovirus/diagnóstico , Feminino , Teste de Histocompatibilidade , Humanos , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Ativação Linfocitária/imunologia , Contagem de Linfócitos , Masculino , Neoplasias/imunologia , Infecções Oportunistas/diagnóstico , Projetos Piloto , Ativação Viral/imunologia
3.
Z Orthop Ihre Grenzgeb ; 113(1): 110-8, 1975 Feb.
Artigo em Alemão | MEDLINE | ID: mdl-168697

RESUMO

The results of 42 cases of compression arthrodesis of the knee joint during a 5.5 years period are reviewed. Main indications were degenerative, rheumatoid and posttraumatic arthrosis and tuberculosis of the knee joint. Other differential indications and the operative procedure following the Charnley-Müller method are described. The complications - pseudarthrosis, infection, false rotation - are discussed.


Assuntos
Artrodese/métodos , Articulação do Joelho , Adulto , Idoso , Artrite Reumatoide/cirurgia , Feminino , Humanos , Inflamação , Artropatias/cirurgia , Prótese Articular , Masculino , Pessoa de Meia-Idade , Osteoartrite/cirurgia , Pressão , Pseudoartrose/cirurgia , Sarcoma Sinovial/cirurgia , Tuberculose Osteoarticular/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA